Abstract. MicroRNAs (miRNAs) are important gene regulators that participate in tumorigenesis. Previous studies have implicated that miR-214 is a tumor suppressor that is capable of inhibiting human hepatocellular carcinoma (HCC) cell growth. However, the mechanism by which miR-214 suppresses tumor development remains unknown. In the present study, miR-214 was observed to suppress tumor proliferation by directly targeting E2F transcription factor 3 (E2F3) in HCC cells. Colony formation, cell cycle and proliferation assays were employed to study the tumor suppressor role of miR-214 in cell proliferation. In addition, western blotting and dual-luciferase reporter assays were used to evaluate whether E2F3 was a target of miR-214. The results of these analyses revealed that E2F3 was a novel target of miR-214. Furthermore, enhanced expression of miR-214 or silencing of E2F3 inhibited the proliferation of HCC SMMC-7721 cells. These findings suggest that miR-214 suppresses HCC growth by targeting E2F3, and may provide a novel approach for the treatment of human HCC.
Introduction
Hepatocellular carcinoma (HCC) is one of the most common types of malignancy and the third leading cause of cancer-associated mortalities worldwide, due to its poor prognosis and frequent relapse and metastasis (1, 2) . Furthermore, HCC is difficult to treat, since it is usually diagnosed at advanced stages (3) . Thus, studying the molecular mechanism of HCC in order to identify novel prognostic markers or therapeutic targets for the treatment of HCC is of value.
MicroRNAs (miRNAs) are small noncoding RNAs of ~22 nucleotides (nt) in length that regulate gene expression at the post-transcriptional level (4) . miRNAs are initially transcribed as long primary precursor molecules named pri-miRNAs, which are processed in a number of endonuclease reactions to produce the mature effector 22-nt miRNA molecule (5) . Through the specific targeting of the 3'-untranslated regions (3'-UTRs) in the target genes of the miRNA, the translational repression and degradation of their target mRNA occurs (6) . By targeting various transcripts, miRNAs are involved in a number of fundamental biological processes, including cell proliferation and differentiation, apoptosis, development and metabolism (7) (8) (9) . Previous studies suggest that the expression of miRNAs is remarkably dysregulated in cancer, due to numerous epigenetic and genomic alterations (10, 11) . Several miRNAs have been demonstrated to act as tumor suppressor genes or oncogenes in tumors (12) . As one miRNA may potentially regulate numerous mRNAs, it is clear that they are important regulatory molecules. Consistently, previous studies have considered miRNAs as important biomarkers and promising therapeutic targets for the treatment of various diseases (13) . Recently, miR-214 was reported to be involved in certain types of cancer, including breast (14) , adrenocortical (15), ovarian (16) and gastric cancer (17) . Thus, the roles of miR-214 may be critical in the development of cancer.
In the present study, bioinformatics analysis was performed to assess E2F transcription factor 3 (E2F3) as a potential target of miR-214, and in vitro experiments were conducted to investigate the effect of overexpression of miR-214 or silencing of E2F3 in HCC proliferation. Furthermore, in HCC cells overexpressing miR-214, the cell cycle distribution was analyzed. The protein levels of cyclin D1 (CCND1) and cyclin-dependent kinase 6 (CDK6) were measured and dual-luciferase reporter assays were conducted in these cells. Luciferase reporter assay. PmirGLO-E2F3-3'-UTR-WT or pmirGLO-E2F3-3'-UTR-Mut vectors were cotransfected with miR-214 into HEK293 cells, using Lipofectamine 2000 (Invitrogen Life Technologies). Firefly luciferase activity was measured at 48 h post-transfection, using a Dual-Luciferase Reporter Assay System (Promega Corporation), according to the manufacturer's instructions. The results were normalized with Renilla luciferase. Each reporter plasmid was transfected ≥3 times, and each sample was assayed in triplicate.
Materials and methods

Cell
Cell proliferation (MTT) and colony forming assays.
For the MTT assay, SMMC-7721 cells were seeded at a density of 5,000 cells/well into 96-well cell culture plates, and transfected with miR-214 inhibitor, si-E2F3 or the corresponding control, using Lipofectamine 2000. Cells were incubated for 24, 48 or 72 h at 37˚C in a humidified incubator with 5% CO 2 , followed by 4-h incubation in the presence of 20 µl MTT (Sigma-Aldrich, St. Louis, MO, USA). Next, the supernatant was removed, and 150 µl dimethyl sulfoxide (Guangdong Guanghua Sci-Tech Co., Ltd., Shenzhen, China) was added to the cells, prior to measurement of their absorbance at 490 nm in a FLUOstar OPTIMA microplate reader (BMG Labtech GmbH, Ortenberg, Germany). For the colony forming assay, SMMC-7721 cells were seeded at a density of 500 cells/well into 6-well plates, and transfected with miR-214, miR-ctrl, Ethical approval. The present study was approved and supervised by the Medical Ethical Committee of the College of Medicine, Xi'an Jiaotong University (Xi'an, China).
Results
E2F3 is a direct target of miR-214.
Among the large number of potential target genes of miR-214, E2F3 was selected for further analysis. Subsequently, a binding site for miR-214 was identified in the 3'-UTR of the E2F3 mRNA (Fig. 1A) . In order to confirm whether miR-214 directly targets E2F3, 3'-UTR fragments of E2F3 were constructed, which contained a wild-type (WT) or mutant (Mut) binding site for miR-214. These binding sites were cloned into the region downstream of the pmiRGLO dual-luciferase reporter vector, and HEK293 cells were cotransfected with miR-214 and pmirGLO-E2F3-3'-UTR-WT or pmirGLO-E2F3-3'-UTR-Mut or pmirGLO. In the pmirGLO-E2F3-3'-UTR-WT group at 48 h, miR-214 significantly reduced the firefly luciferase activity, compared with pmirGLO (P<0.05; Fig. 1B ), indicating that miR-214 may target directly the binding sequences at the 3'-UTR of E2F3. No significant difference was observed between the miR-214 and pmirGLO in the pmirGLO-E2F3-3'-UTR-Mut group. Furthermore, the transfection of miR-214 in the SMMC-7721 cells led to reduced expression of E2F3 at the protein level (Fig. 1C) , demonstrating that miR-214 directly targeted E2F3. 
miR-214 induces G 1 -S phase arrest and inhibits cell proliferation by suppressing E2F3-dependent cell cycle regulation.
Overexpression of miR-214 led to a significant increase in the percentage of cells in G 0 /G 1 phase, compared with the control (P<0.05; Fig. 3A) . Similarly, si-E2F3 led to an increase in G 0 /G 1 phase cells and a reduction in S phase cells, compared with the si-ctrl (P<0.05; Fig. 3B ) at 48 h. Furthermore, overexpression of miR-214 reduced the expression levels of E2F3 in SMMC-7721 cells, compared with the control treatment (Fig. 3C) , which was in agreement with the results of the treatment with si-E2F3 (Fig. 3D) . These findings suggest that miR-214 may induce the G 1 -S phase arrest of SMMC-7721 cells and suppress cell growth by targeting E2F3. oligonucleotides were used to silence the expression of miR-214. The inhibition of miR-214 increased the proliferation of SMMC-7721 cells, as indicated by the MTT assay (Fig. 4A) . The inhibitor of miR-214 promoted colony formation and induced G 1 -S phase transition in SMMC-7721 cells (P<0.05; Fig. 4B and C) . Furthermore, cells transfected with miR-214-inhibitor oligonucleotides exhibited increased expression levels of E2F3, as determined by western blot analysis (Fig. 4D) . Taken together, these results demonstrated the important contribution of endogenous miR-214 to the proliferation of SMMC-7721 cells in liver cancer progression.
Inhibition of miR-214 contributes to proliferation of
Discussion
HCC is the third leading cause of cancer-associated mortalities worldwide, resulting in >600,000 mortalities/year, and a 5-year survival rate of <5% when left untreated (18) . However, the molecular mechanisms of HCC remain largely unknown. Recent evidence has suggested that miRNAs may be involved in the progression of human cancer, since numerous miRNAs have been observed to be deregulated during tumorigenesis in humans (19) . Previous studies have demonstrated that miR-214 is downregulated in cervical cancer and upregulated in human pancreatic cancer (20, 21) . The present study has demonstrated that the expression of miR-214 was downregulated in HCC tissues and cell lines. Therefore, miR-214 may be a tumor suppressor miRNA.
E2F3 is a member of the E2F family of transcription factors, which participate in the regulation of diverse cellular processes, including cell differentiation and proliferation (22) . E2Fs are involved in the regulation of the transcription activity required for the induction of the S phase of the cell cycle, during the transition from quiescence to proliferation (23) . The proliferation of eukaryotic cells is divided into 4 phases: G 1 , S, G 2 and M, as reviewed by Malumbres and Barbacid (24) and Yang et al (25) . The activity of E2Fs is regulated by the retinoblastoma protein (pRB), a tumor suppressor that is functionally inactivated in the majority of human tumors. E2F transcription factors contain various heterodimers, each of which is composed of 1 E2F and 1 DP subunit (26) . The family members E2F1, 2 and 3 predominantly associate with pRb, and each of these E2Fs are sufficient to induce quiescent cells to enter the S phase through a period of high transcriptional activity (27) . Previous studies conducted in cells of higher eukaryotes have indicated that cyclin D-dependent kinases CDK4 and 6 possibly regulate the G 1 -S phase transition by phosphorylating pRb, and consequently releasing the E2F transcription factors. In the present study, miR-214 was able to suppress the growth of SMMC-7721 cells by targeting E2F3, and arrest the cell cycle progression at the G 1 phase. In addition, the relative expression of the cell cycle regulatory protein E2F3 was reduced by miR-214. Furthermore, si-E2F3 and an inhibitor of miR-214 were used to evaluate the biological effects of miR-214 in HCC SMMC-7721 cells. The previously observed effects on cell proliferation due to the In conclusion, in the present study miR-214 was demonstrated to directly target E2F3 and induce cell cycle arrest at the G 1 phase. Furthermore, miR-214 suppressed the growth of HCC SMMC-7721 cells through targeting E2F3. Therefore, these data suggest that miR-214 may be a tumor suppressor and potential therapy for the treatment of HCC in the future.
